Volume : 13, Issue : 11, November – 2026
Title:
FORMULATION AND EVALUATION OF CONTROLLED RELEASE MATRIX TABLETS OF PROPRANOLOL HYDROCHLORIDE FOR HYPERTENSION
Authors :
Dr. R Sridhar Babu, Syed Asimuddin, Ameen Fatima, Sana Begum, Syed sami ahmed
Abstract :
The aim of the present work is to formulate and evaluate sustained release of Propranolol matrix tablets used for treatment of Hypertension. Formulate of CR Propranolol is proposed considering the adverse event profile and high fluctuation index of Propranolol observed with CR dosage forms. Propranolol was subjected to Preformulation studies, based on the results obtained Propranolol controlled release tablets were successfully formulated. Formulations prepared by direct compression technique. Set of trials were formulated for which Propranolol evaluated parameters (bulk density, tapped density, compressibility index, Hausner’s ratio, weight, thickness, hardness) were found to lie within the specifications. Dissolution study was performed in USP type II apparatus at 100 RPM in pH 6.8 phosphate buffer. From the results of the in vitro study it appears that the release of the Propranolol was significantly influenced by the characteristics of the polymer used.
Keywords: Propranolol Hydrochloride, polymers, FTIR studies, Direct compression technique, In vitro drug release studies.
Cite This Article:
Please cite this article in press R Sridhar Babu et al., Formulation And Evaluation Of Controlled Release Matrix Tablets Of Propranolol Hydrochloride For Hypertension.,. Indo Am. J. P. Sci, 2026; 13(11).
REFERENCES:
1. Diclofenac controlled release tablets employing olibanum resin, IJPSR, 2012; Vol. 3(4): 1090-1095
2. Dwarakanadha Reddy peram, Surya prakash,A, Swarnalatha.D, Usha Sree , Formulation and Evaluation of Ethyl Cellulose Coated Microcapsules of Glibenclamide for Controlled Release, Asian Journal of Chemistry; Vol. 26, No. 3 (2014), 770-772
3. Sujata D. Bansode, Veena S. Kasture, Sarita S. Pawar, Sanjay B. Kasture, Formulation and evaluation of telmisartan microspheres by emulsion solvent evaporation technique, Journal of Applied Pharmaceutical Science Vol. 2 (10), pp. 113-116, October, 2012.
4. GR. Girish Reddy, Design and Evaluation of Sustained Release Capsule of Telmisartan, international journal of advances in pharmacy, biology and chemistry, Vol. 1(3), Jul- Sep, 2012.
5. Avachat, A., and V., Kotwal, 2007 Design and evaluation of matrix-based controlled release tablets of diclofenac sodium and chondroitin sulphate. AAPS PharmSciTech. 8(4):E88. [PMID: 18181548]
6. Kulkarni G.T, Gowthamarajan K, Suresh B. stability testing of pharmaceutical product: an overview. Indian J Phar Edu. 2004, 38(4): p.no.194-202
7. 71) Kanvide S A, Kulkarni M S, Stability of oral solid dosage form: A global perspective. Pharma Time 2005,37(5):p.no. 9-15
8. 72) Mohrle R. Effervescent tablets in Liberman HA, Lachman L, editor. Pharmaceutical dosage form –Tablet, Marcel Dekker Inc, New York:1980, p.no. -232-246(vol-1)
9. 73) Khan G.M., Zhu J.B, “Studies on drug release kinetics from ibuprofun carbomer hydrophilic matrix tablets” J. Cont. Rel.,1999, 57, p.no.197-203.
10. 74) Hoyashi T, Kanbe H, Okado M. Suzuki M, Sonobe T. “formulation study and drug release mechanism of a new theophylline Sustained Release preparation” Int. J. Pharm, 2005,304, p.no. 91-101.
11. 75) Solinis M.A, Cruz Y. De, Gascon A, Calvo B, Pedraz J. L “Release of Ketoprofen enantiomeres from HPMC K100M matrices –Diffusion studies” Int. J. Pharm., 2002,239, p.no. 61-68.
12. 76)Qiu Y. Chidambaram N, Porter W. Flood K., “Formulation and characterization of new diffusional matrices for Zero – order sustained release” J. Cont. Rel., 1998,52, p.no.149-158.
13. Leon Shargel, Susanna Pong, Andrew B.C., Applied Biopharmaceutics and Pharmacokinetics, Modified-Release Drug Products, Pg 515 Fifth Edition, 2004
14. Chien Y.W., Controlled- and modulated-release drug-delivery systems. Encyclopedia of pharmaceutical technology. New York, Dekker, pgs 281-313, 1992.
15. J. R. Robinson, S. P. Eriksen, Theoretical formulation of sustained-release dosage forms.J Pharm Sci. 1966.
16. Gilbert S. Banker, Christopher T. Rhodes, Modern Pharmaceutics, Sustained – and Controlled -release drug-delivery systems, Pg 505 Fourth Edition, 2002